Conclusions High degree of sexual satisfaction was paradoxically associated with reported severe lubrication difficulties and sexual desire, arousal, orgasmic and pain disorders. It seems that reported quality of sexual satisfaction and objective female sexual function do not necessarily correlate.
PS-5-9
Efficacy of functional electrical stimulation (FES)-biofeedback with cognitive behavioral therapy as a treatment of vaginismus J. T. Seo, Republic of Korea; K.-H. Kim, J.-S. Lee, W. S. Lee
Objectives Vaginismus is involuntary vaginal muscle contraction that leads to difficult or impossible sexual intercourse. Various therapeutic approaches have been considered physiologically and psychologically. We report twelve cases of vaginismus which were successfully treated with FES-biofeedback with cognitive behavioral therapy. Our objective was to determine the efficacy of FES-biofeedback with cognitive behavioral therapy as a standard therapy for vaginismus. Design and Methods Twelve women with vaginismus waiting for a clinical checkup participated in this study. Patients enrolled in this study had vaginismus with the criteria of DSM-IV and ICD-10. The patients were assessed at pretreatment and posttreatment follow-up via gynecological examination and structured interviews pertaining to sexual function and psychological adjustment. After the diagnosis of vaginismus, we conducted a pelvic floor muscle relaxation by FESbiofeedback once a week. When the patients became tolerable to vaginal manipulation, the 8-staged gradual desensitization using vaginal self-dilation with fingers and vaginal probe insertion were added for 8 weeks.
Results At 8 weeks of treatment, all 12 women who completed the program became tolerable to vaginal insertion of larger size probes and could achieve satisfactory vaginal intercourse. Conclusions FES-biofeedback with behavioral cognitive therapy is an effective aid to learning the muscle control in patients with vaginismus. Therefore, it may increase the success rate of treatment of vaginismus. Objectives The MALES Study-II is aimed at understanding and validating self-reports of severity of erectile dysfunction (ED) among men with this disorder. Methods 3,775 men from 8 countries (US, UK, Germany, France, Italy, Spain, Mexico, and Brazil), aged 20-75 years and with some degree of self-reported ED, were recruited through participation in MALES-I and booster methods. We examined the relationship between self-reported severity of ED and self-reports of relevant characteristics of sexual function including: I get no erection at all; I have difficulty getting a sufficiently good erection; I get satisfactory erections but they don't last long enough; percent reduction in sexual activities of any kind; temporal duration of ED; and perceived temporary or permanent nature of ED. Results The severity of self-reported ED strongly correlated with perceptions of ED sufferers that their ED is permanent and associated with reduction in sexual activity (Po0.0001). Self-reported ED severity didn't correlate with disease duration. In addition, men with mild ED were more likely to describe their problem as one of maintaining an erection; men with moderate ED were more likely to cite difficulties achieving a sufficiently good erection; men with severe ED were more likely to report getting no erection at all. Conclusion These data validate a simple self-reported measure of ED severity, and provide an insight into perceptions of ED sufferers that may be valuable to clinicians treating men with ED, and to understanding treatment-seeking behavior of men with ED.
PS-6-2
Sexual activity, attitudes and problems in european adults aged 40 to 80 years: Results of an international survey Results Approximately half of the men reported that sex was a very or extremely important part of their life; the figure was higher in Southern Europe (59%) compared with Northern Europe (44%). This difference was smaller among women (36% vs 30%). More Southern than Northern European men reported having at least one episode of sexual intercourse in the last 12 months (88% vs 81%); among women the figures were 73% and 68%. Similar numbers of subjects in Northern and Southern Europe reported experiencing one or more specific sexual problems for at least 2 months during the past year (39% and 38% in men and 46% and 48% in women, respectively). Erectile difficulties were reported by 13% of men from both Northern and Southern Europe; in Northern Europe their prevalence increased from 7% at 40-49 years to 24% at 70-80 years and in Southern Europe from 6% to 21%. Among women, the frequency of lubrication difficulties was similar in Northern and Southern Europe (18% and 16%, respectively), with peak prevalence seen at 60-69 years (26% in Northern and 20% in Southern Europe). Conclusions Most European adults are sexually active into middle and older age, with sex remaining an important part of life. Sexual problems are common among men and women throughout Europe.
PS-6-3
ESSM survey of men and women attitudes toward sexual health across Europe Foreword ESSM, by means of Makno & Consulting, performed a Survey on European men and women attitudes toward sexual health, with three distinct goals: 1 gather information on the most appropriate media to improve information on sexual health; 2 investigate knowledge of both: pathologies affecting sexual function, and medical specialties aimed at solving/treating them; 3 investigate attitudes and behaviors when a sexual disorder occurs. Methodology The Survey has been carried out on February 2003 in seven European countries: Denmark, France, Germany, Hungary, Italy, Spain, United Kingdom. It consisted of 1.000 interviews/country on prearranged percentages of males (70%) and females (30%), age range: 40-69 years. During a Computer Assisted Telephoning Interview (CATI) a questionnaire containing 18 fully structured questions was administered. Results Media to provide information on sexual health. In all countries television resulted the most effective media, followed by press (especially magazines), and radio. -Knowledge of which medical specialist deals with sexual health -MenOverall knowledge level resulted low (28-69% did not know), the most mentioned professional being the Urologist (range: 10-63%). In Italy the Andrologist scored the highest (41%); notably, there an ''Andrological Prevention Week'' is taking place yearly, since 2001. Women-The gynecologist emerged as the specialist for female sexual health disorders (range: 40-82%).
-Prevention of sexual health disorders: 4-17% only (mostly women) had one check-up for prevention purposes on sexual health. Data widely vary across Europe. Conclusions The ESSM Survey showed that in many European countries it is high the percentage of men and women that need both education on sexual issues and clear references on who is the medical specialist dealing with sexual health. Campaigns as the ESSM Sexual Awareness Event move in the direction to fulfill such need.
PS-6-4
Does the association between male sexual function and LUTS have a psychological origin?
I. Eardley, United Kingdom; Z. Hussain, C. Johnston, S. Sak Introduction There is considerable interest in the relationship between lower urinary tract symptoms (LUTS) and male sexual function, and in particular whether there is a causal relationship between them. This observational study, performed in a single centre, seeks to explore this issue further. Patients and Methods 1420 men were assessed by International Prostate Symptom Score (IPSS), BPH impact index (BPHII), urinary flow rate (Qmax), post-void residual volume (PVR) and the O'Leary sexual function inventory (SFI). The results were analyzed using univariate and multiple linear regression models with the domains of the SFI as the outcome variable.
Results Following exclusion of those with incomplete data, those who were not sexually active, those with PSA 420ng/ml and those who refused to fill in the questionnaire, there were 696 evaluable patients. The relationship between LUTS and SFI was complex and varied according to the sexual function domain. Using univariate analysis the erectile domain, the ejaculatory domain and sexual drive domain all correlated with both age and IPSS. However, when multivariate analysis was used the relationship was much more complex (Table 1) and IPSS was not an independent predictor of any of the domains. For erectile function, age (po0.001), QOL (po0.005) and BPHII (p¼0.01) were independent predictors, for ejaculatory function only age (po0.001) was an independent predictor and for sexual drive, age (po0.001) and QOL (p¼0.01) were independent predictors. Conclusion A significant proportion of men with LUTS have sexual dysfunction. However, the dominant predictor of sexual function is the patient's age. Some aspects of sexual function may be directly related to the bother associated with any urinary symptoms
PS-6-5
Erectile function of patients with renal replacement therapy O. Sanli, Turkey; M. Atar, A. Kadioglu, M. S. Sever, A. Turkmen, K.
N. Tutucu
Introduction Aim of this study is to evaluate the erectile function in male renal failure patients treated with renal replacement therapy and investigate the relationship between the severity of ED and clinical parameters of functioning kidney. Material & methods 74 patients were recruited to the study. All patients were evaluated with IIEF and also 55 of them were evaluated with Beck's depression inventory. According to the scores of IIEF, patients were classified for the severity of ED. Meanwhile, the following clinical data were observed: age, period of dialysis, duration of renal replacement, etiology of ED (risk factors for cystemic vascular disease), use of concomitant medications and immunosupressive drugs. Also creatinine, hemoglobine, prolactine, parathyroid and thyroid hormones, gonadotropin levels and testosterone levels were determined and compared with each of the groups. CDU and CIS test were performed to 18 and 15 patients who had desire for invasive evaluation, respectively. Results Mean age and period of dialysis of patients with ED(35, 47.3%) and without ED(39, 52.7%) were 45.278.0, 39.378.6 (p:o0.05) years and 31.0726, 24.7720 months (p:0.19) respectively. Duration of renal replacement was not significant between two groups. Of the patients 37.1%(13), 28.5%(10), 34.2(12) had severe, moderate and mild ED respectively. Overall, significantly affected domains of IIEF were orgasm and general satisfaction. In ED group, 8(18%) patients had depression (7 minor, 1 major), while it was detected in 4(19%) patients (3 minor, 1 minor) without ED (p: NS). No correlation was found between ED and all laboratory and clinical parameters except parathormone and prolactine levels. In ED group, CDU revealed cavernosal insufficiency in 3(20%) and rest of the patients were normal for erectile status.
Conclusions ED is extremely prevalent among patients with renal replacement therapy. Despite many individual factors, age seems to play a major role in such patients.
PS-6-6
Correlation of creatinine clearance and erectile dysfunction in patients with chronic renal failure S. Papadoukakis, Greece; C. Alamanis, A. Giannopoulos, D. Mitropoulos, E. Psimenou
Objectives Erectile dysfunction, loss of libido, and infertility are common urologic problems among patients with chronic renal failure. It is estimated that almost 40% of patients with chronic renal failure, in their 40's suffer from erectile dysfunction. We tried to determine the correlation between creatinine clearance (CC) and severity of erectile dysfunction (ED) in patients with renal failure. Design and Method 129 patients of the Nephrology department were classified in three groups according to their creatinine clearance as determined by the Cockroft-Gault formula. Group A consisted of 42 patients with mild renal failure having CC 450 ml/sec, group B consisted of 44 patients with moderate renal failure with CC between 25 ml/sec and 50 ml/sec and finally group C consisted of 43 patients with severe renal failure having CCo25 ml/sec. All patients filled in the IIEF questionnaire Results An IIEF score higher than 20 indicated normal erectile function, while scores less than 18, 11, and 6 indicated mild, moderate and severe erectile dysfunction, respectively. We noted that the majority of patients in group A reported mild (42,85%) and moderate (30,09%) ED, while in group B there was a shift of the IIEF score towards moderate (45,45%) and severe (29,54%) ED and finally almost half of the patients (51,16%) in group C reported severe ED. Conclusion The results of the study support the fact that there is a statistical significant correlation between erectile dysfunction reported by patients with chronic renal failure and the level of their renal function as estimated by their creatinine clearance. We attribute those findings to the accumulating effect of uraemia overtime to the blood vessels, along with offensive pharmacological factors (anti-hypertensives), and chronic anaemia.
PS-6-7
Erectile dysfunction in chronic obstructive lung disease N. Ko¨seoglu, Turkey; E. Ceylan, H. A. Cimrin, A. A. Esen, H. Ko¨seoglu, S. Ozalevli
Objective We assessed the erectile dysfunction and sexual status in the outpatients with Chronic Obstructive Airway Disease (COPD) and its relation to patients' physical status . Study design Between October 2002 and June 2003, 60 outpatients with COPD visiting pulmonary department were enrolled into this study with a written informed consent. Patients were asked to complete IIEF and Duke activity status forms and to have physical examination including urogenital examination and pulmonary assessment with spirometry measurement, six minute walk test and arterial blood sample. All of the patients with COPD were graded with Global Initiative for Chronic Obstructive Lung Disease (GOLD) staging system according to these tests. 53 patients were assessed for statistical analysis. Results Patients' mean age was 63.3877,32 years (48-80) . Patients were found to be COPD with GOLD stages of 1 (mild) (13,2%), 2A (moderate; FEV1: 50-80% ) (34%),2B (moderate ; FEV1:30-50%) (49,1%) and 3 (severe) (3,8%). 15,1% of the patients had coronary artery disease. 34% of the patients had hypertention. 22,6% of the patients had hyperlipidemia. 15,1% of the patients had diabetes mellitus type II. 49% of the patients had no comorbid disease for ED. According to IIEF-ED domain 75,5 % of patients were found to have ED with varying degrees ( severe ED 28.3%, moderate ED 11.3% , mild to moderate ED 15.1% and mild ED 20.8% ) and % 24,5 had no ED. A correlation was determined between severity of COPD and severity of ED. Conclusions Physical restrictions of patients with COPD also limited the sexual function of these patients. This point must be kept in mind in evaluation of these patients with COPD.
PS-6-8
Homocysteine: A new mediator in erectile dysfunction A. Esen, Turkey; L. Argun, S.-Ç . Aytaç -Gu¨lcu¨, Ö . Demir, T. Demir, S.-Y. Mustafa-Seç il, A. Ç o¨mlekç i
Introduction Nitric oxide (NO) is a common mediator which plays an important role in endothelial and erectile function. NO synthase (NOS) is responsible for the production of NO that can be inhibited by several endogenous and exogenous factors such as hypercholesterolemia, smoking, etc. Recently it has been shown that hyperhomocysteinemia had an inhibitory effect on NOS activity. In this study we investigated the role of homocysteine (Hcys) in erectile dysfunction (ED).
Method Sixty-four patients who were admitted our university hospital were included in this study. While 31 of them had complaints of ED, rest of the patients without ED complaints constitued the control group. Patients who had concomitant comorbidities for ED such as diabetes, coronary artery disease, hipotiroidism, etc. were excluded from this study. All of the patients were asked to complete the IIEF questionaire. The IIEF-ED domain scores were used for statistical analysis. Fasting blood glucose, total cholesterol, triglycerid, HDL cholesterol, LDL cholesterol and Hcys levels were determined. Color penil duplex ultrasonography was performed in patients with ED. Peak systolic and diastolic velocity were determined 1, 5, 10 and 20 minutes after intracavernosal injection. Data were analyzed using ANOVA and Pearson logistic regression analysis. Results Plasma levels of the ED and control groups's parameters were shown in table. Hcys was the only parameter significantly correlated with IIEF-ED domain score. Hcys levels of ED patients were determined to be negatively correlated with peak systolic velocities at 1, 5 and 10 minutes. Conclusions Hcys is a promising risk factor for ED which may exerts its effect by impairing the arterial inflow.
PS-6-9
The ''Cologne 20.000 community survey'' -Prevalence and therapy necessity of men with erectile dysfunction M. Braun, Germany; U. Engelmann, N. Jawadi, R. Jawadi, F. Sommer
Objectives Since the introduction of Sildenafil (1998) there was an big increase of knowledge about the pathology of ED. In the year 1998 we conducted the Cologne (8000) Men Survey. This population based study, showed an ED-prevalence of 19.2%. Interestingly only one third of the ED sufferer needed any therapy. With introduction of new therapy modalities we expected, a significant change of these data. Material & Methods We developed and validated a questionnaire (''KEED''; Cologne assessment of erectile dysfunction). It represents a suitable instrument for epidemiological investigations and was also used in the ''Cologne 8000 Men Survey''. In addition treatment modalities, IPSS and other risk factors were evaluated. The questionnaire has been sent three times to 20.000 people (30-80 years, age standardised, 10.000 males, 10.000 females) in the Cologne area. Results Response rate for the male population was 46% (4611 men). The prevalence of erectile dysfunction was age related. Overall 20.8% (963 men) reported on erectile dysfunction, while only 6.1% (283 men) suffered from this malfunction. We identified the well known riskfactors, as Diabetes mellitus, Hypertension and arterial disturbance. There was again a strong correlation between ED-Score and IPSS. Approximately 90% preferred oral medication. Implantation of penile prosthesis has been elected to be the last choice in the therapy of erectile dysfunction. Conclusions The data of this new study are supporting the data of the Cologne Male Survey (1998). The prevalence of severe ED is similar 20.8 vs. 19.2 Only almost one third of the men with ED need any therapy. The well known risk factors like hypertension, diabetes mellitus and operation of the small pelvis could again be identified. There is an important impact of these condition on QoL.
Moderated Poster Session 9 MP-9 Peyronie, priapism, trauma Wednesday, November 19, 2003 11:30 -12 Objectives Transforming growth factor-b1 (TGF-b1) has been implicated in cavernous fibrosis, and resultant erectile dysfunction. For further elucidation of TGF-b1 signaling in association with cavernous fibrosis, we developed a rat model of cavernous fibrosis using TGF-b1-producing NIH3T3 fibroblasts (NIH3T3-TGF-b1). Design and Methods Male Sprague-Dawley rats were classified into three groups: Group 1; those receiving culture media (control, 0.1Ml), Group 2; recombinant human TGF-b1 protein (200 ng/0.1 Ml), Group 3; NIH3T3-TGF-b1 cells (3 Â 10 6 /0.1 Ml). At 20 days postinjection, erectile function was assessed by electrostimulation of the cavernous nerves. The penis was removed and then Masson's trichrome and immunohistochemical staining for TGF-b1 and its type II receptor were performed. RT-PCR was performed to investigate the expression of exogenous TGF-b1 transcript after injection of the NIH3T3-TGFb1 cells. Results Masson's trichrome staining at 20 days postinjection showed multiple fibrous scars in group 3, while no histologic evidence of cavernous fibrosis in group 1 and 2. Immunohistochemical staining revealed higher expression of TGF-b1 and its type II receptor in group 3 than in group 1 or 2. During the electrostimulation of the cavernous nerve maximal intracavernous pressure was significantly lower in group 3 (67.9724.9 cm H 2 O) compared to group 1 (114.8711.4 cm H 2 O) or group 2 (113.9713.5 cm H 2 O) (Po0.01). The expression of exogenous TGF-b1 transcripts peaked at 5 days postinjection and continued to 10 days after injection of the cells. Conclusions NIH3T3-TGF-b1 cells sufficiently induced relatively long-lasting cavernous fibrosis. This model may contribute to further investigation of the pathogenesis of penile fibrosis associated with TGF-b1 signal and development of new therapeutics targeting this pathway.
MP-9-2
Clinical presentation of peyronie's disease in young patients 
